Endoplasmic Reticulum Ca2+ Handling in Excitable Cells in Health and Disease

被引:196
作者
Stutzmann, Grace E. [1 ]
Mattson, Mark P. [2 ]
机构
[1] Rosalind Franklin Univ, Chicago Med Sch, Dept Neurosci, N Chicago, IL 60064 USA
[2] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA
基金
美国国家卫生研究院;
关键词
CALCIUM-RELEASE CHANNEL; CARDIAC RYANODINE RECEPTOR; LONG-TERM POTENTIATION; POLYMORPHIC VENTRICULAR-TACHYCARDIA; ISCHEMIA-REPERFUSION INJURY; CALHM1 P86L POLYMORPHISM; SPONTANEOUS BEATING RATE; HIPPOCAMPAL CA1 NEURONS; NECROSIS-FACTOR-ALPHA; CAFFEINE-INDUCED CA2+;
D O I
10.1124/pr.110.003814
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The endoplasmic reticulum (ER) is a morphologically and functionally diverse organelle capable of integrating multiple extracellular and internal signals and generating adaptive cellular responses. It plays fundamental roles in protein synthesis and folding and in cellular responses to metabolic and proteotoxic stress. In addition, the ER stores and releases Ca2+ in sophisticated scenarios that regulate a range of processes in excitable cells throughout the body, including muscle contraction and relaxation, endocrine regulation of metabolism, learning and memory, and cell death. One or more Ca2+ ATPases and two types of ER membrane Ca2+ channels (inositol trisphosphate and ryanodine receptors) are the major proteins involved in ER Ca2+ uptake and release, respectively. There are also direct and indirect interactions of ER Ca2+ stores with plasma membrane and mitochondrial Ca2+-regulating systems. Pharmacological agents that selectively modify ER Ca2+ release or uptake have enabled studies that revealed many different physiological roles for ER Ca2+ signaling. Several inherited diseases are caused by mutations in ER Ca2+-regulating proteins, and perturbed ER Ca2+ homeostasis is implicated in a range of acquired disorders. Preclinical investigations suggest a therapeutic potential for use of agents that target ER Ca2+ handling systems of excitable cells in disorders ranging from cardiac arrhythmias and skeletal muscle myopathies to Alzheimer disease.
引用
收藏
页码:700 / 727
页数:28
相关论文
共 340 条
[71]  
Darby Peter J., 1993, Biological Signals, V2, P293
[72]   Genetic Animal Models of Parkinson's Disease [J].
Dawson, Ted M. ;
Ko, Han Seok ;
Dawson, Valina L. .
NEURON, 2010, 66 (05) :646-661
[73]   Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a [J].
del Monte, F ;
Harding, SE ;
Schmidt, U ;
Matsui, T ;
Kang, ZB ;
Dec, W ;
Gwathmey, JK ;
Rosenzweig, A ;
Hajjar, RJ .
CIRCULATION, 1999, 100 (23) :2308-2311
[74]   Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling [J].
del Monte, F ;
Lebeche, D ;
Guerrero, JL ;
Tsuji, T ;
Doye, AA ;
Gwathmey, JK ;
Hajjar, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (15) :5622-5627
[75]   Calcium Signaling and Amyloid Toxicity in Alzheimer Disease [J].
Demuro, Angelo ;
Parker, Ian ;
Stutzmann, Grace E. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (17) :12463-12468
[76]   Malignant hyperthermia [J].
Denborough, M .
LANCET, 1998, 352 (9134) :1131-1136
[77]  
Denmeade SR, 2005, CANCER BIOL THER, V4, P14
[78]   Translating preclinical insights into effective human trials in ALS [J].
DiBernardo, Allitia B. ;
Cudkowicz, Merit E. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2006, 1762 (11-12) :1139-1149
[79]  
DIETRICH J, 1976, THERAPIE, V31, P525
[80]   Structure of the human sarco/endoplasmic reticulum Ca2+-ATPase 3 gene -: Promoter analysis and alternative splicing of the SERCA3 pre-mRNA [J].
Dode, L ;
De Greef, C ;
Mountian, I ;
Attard, M ;
Town, MM ;
Casteels, R ;
Wuytack, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13982-13994